BPC-157 is soluble in DMSO at concentrations up to approximately 5 mg/mL, and DMSO is typically selected when preparing concentrated stock solutions for cell culture assays where final DMSO concentration in the well can be kept below 0.1% to avoid cytotoxicity artifacts
These innovations aim to enhance bioavailability, reduce dosing frequency, and improve patient compliance [24]
Wongsantichon J, Ketterman AJ (2005) Alternative splicing of glutathione S-transferases
[247] In April 2025, Eli Lilly, represented by Kirkland & Ellis and Walsh Pizzi O'Reilly Falanga, filed a series of lawsuits in federal courts in New Jersey and California against several telehealth and compounding pharmacy companies, including Willow Health Services, Henry Meds, Mochi Health, Fella Health, and Empower Clinic Services, alleging unfair competition, false advertising, and deceptive business practices related to the sale of unapproved compounded tirzepatide products marketed for weight loss
